PortfoliosLab logoPortfoliosLab logo
VIST vs. TGTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VIST vs. TGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vista Oil & Gas, S.A.B. de C.V. (VIST) and TG Therapeutics, Inc. (TGTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VIST achieves a 48.25% return, which is significantly lower than TGTX's 66.12% return.


VIST

1D
-1.21%
1M
5.47%
YTD
48.25%
6M
45.86%
1Y
37.65%
3Y*
48.18%
5Y*
80.45%
10Y*

TGTX

1D
3.06%
1M
16.11%
YTD
66.12%
6M
57.96%
1Y
32.51%
3Y*
21.69%
5Y*
5.57%
10Y*
21.61%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VIST vs. TGTX - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
VIST
Vista Oil & Gas, S.A.B. de C.V.
48.25%-10.07%83.36%88.44%193.81%108.20%-67.39%-4.85%
TGTX
TG Therapeutics, Inc.
66.12%-0.96%76.23%44.38%-37.74%-63.48%368.65%57.45%

Correlation

The correlation between VIST and TGTX is -0.14, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.14

Correlation (3Y)
Calculated over the trailing 3-year period

-0.01

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Jul 26, 2019

0.09

The correlation between VIST and TGTX shifts across timeframes, from -0.14 (1 year) to 0.09 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

VIST:

$7.95B

TGTX:

$7.93B

EPS

VIST:

$6.82

TGTX:

$2.87

PE Ratio

VIST:

10.58

TGTX:

17.23

PEG Ratio

VIST:

0.08

TGTX:

0.03

PS Ratio

VIST:

2.71

TGTX:

11.37

PB Ratio

VIST:

3.06

TGTX:

13.59

Total Revenue (TTM)

VIST:

$2.90B

TGTX:

$700.35M

Gross Profit (TTM)

VIST:

$1.31B

TGTX:

$581.54M

EBITDA (TTM)

VIST:

$2.12B

TGTX:

$156.88M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VIST vs. TGTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VIST
VIST Risk / Return Rank: 6565
Overall Rank
VIST Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
VIST Sortino Ratio Rank: 6666
Sortino Ratio Rank
VIST Omega Ratio Rank: 6363
Omega Ratio Rank
VIST Calmar Ratio Rank: 6464
Calmar Ratio Rank
VIST Martin Ratio Rank: 6565
Martin Ratio Rank

TGTX
TGTX Risk / Return Rank: 6363
Overall Rank
TGTX Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 6464
Sortino Ratio Rank
TGTX Omega Ratio Rank: 6363
Omega Ratio Rank
TGTX Calmar Ratio Rank: 6464
Calmar Ratio Rank
TGTX Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VIST vs. TGTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vista Oil & Gas, S.A.B. de C.V. (VIST) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VISTTGTXDifference
Sharpe ratioReturn per unit of total volatility

+0.07

Sortino ratioReturn per unit of downside risk

+0.12

Omega ratioGain probability vs. loss probability

1.17

1.16

0.00

Calmar ratioReturn relative to maximum drawdown

1.04

1.00

+0.04

Martin ratioReturn relative to average drawdown

2.36

1.81

+0.55

VIST vs. TGTX - Sharpe Ratio Comparison

The current VIST Sharpe Ratio is 0.76, which is comparable to the TGTX Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of VIST and TGTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VIST vs. TGTX - Drawdown Comparison

The maximum VIST drawdown since its inception was -81.19%, smaller than the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for VIST and TGTX.


Loading charts...

Drawdown Indicators


VISTTGTXDifference

Max Drawdown

Largest peak-to-trough decline

-81.19%

-99.52%

+18.33%

Max Drawdown (1Y)

Largest decline over 1 year

-36.48%

-32.66%

-3.82%

Max Drawdown (3Y)

Largest decline over 3 years

-43.36%

-75.42%

+32.06%

Max Drawdown (5Y)

Largest decline over 5 years

-43.36%

-90.75%

+47.39%

Max Drawdown (10Y)

Largest decline over 10 years

-93.19%

Current Drawdown

Current decline from peak

-8.97%

-78.79%

+69.82%

Average Drawdown

Average peak-to-trough decline

-28.22%

-91.43%

+63.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.01%

18.04%

-2.03%

Volatility

VIST vs. TGTX - Volatility Comparison

The current volatility for Vista Oil & Gas, S.A.B. de C.V. (VIST) is 12.74%, while TG Therapeutics, Inc. (TGTX) has a volatility of 15.65%. This indicates that VIST experiences smaller price fluctuations and is considered to be less risky than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VISTTGTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.74%

15.65%

-2.91%

Volatility (6M)

Calculated over the trailing 6-month period

32.81%

34.28%

-1.47%

Volatility (1Y)

Calculated over the trailing 1-year period

49.68%

47.22%

+2.46%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

52.00%

87.77%

-35.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

61.12%

86.88%

-25.76%

Dividends

VIST vs. TGTX - Dividend Comparison

Neither VIST nor TGTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

VIST vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between Vista Oil & Gas, S.A.B. de C.V. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
865.01M
204.92M
(VIST) Total Revenue
(TGTX) Total Revenue
Values in USD except per share items

VIST vs. TGTX - Profitability Comparison

The chart below illustrates the profitability comparison between Vista Oil & Gas, S.A.B. de C.V. and TG Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20222023202420252026
54.6%
83.7%
Portfolio components
VIST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported a gross profit of 472.36M and revenue of 865.01M. Therefore, the gross margin over that period was 54.6%.

TGTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.

VIST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported an operating income of 216.12M and revenue of 865.01M, resulting in an operating margin of 25.0%.

TGTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.

VIST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported a net income of 107.71M and revenue of 865.01M, resulting in a net margin of 12.5%.

TGTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.


Frequently Asked Questions


VIST and TGTX have a correlation of -0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TGTX has higher volatility (15.65%) compared to VIST (12.74%). In terms of maximum drawdown, VIST dropped -81.19% vs TGTX's -99.52%.

VIST currently has the higher Sharpe Ratio (0.76 vs 0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VIST and TGTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer